Delivery Order SPE2DB22D9244-SPE2DB24FZS81

Award Date 9/18/24
Potential Completion Date 10/9/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,187.29 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. This single-award...
This federal contract award, valued at $12,276.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4566185182 - RITUXAN 500 MG/50 ML VIAL 50ML. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,207.51, is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support the medical supply needs of the U.S. Department of Defense (DoD) healthcare facilities. The contract is a firm fixed-price delivery order with no set-aside designation, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $11,931.76 firm fixed-price delivery order for the supply of 4567665741 ! RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,879.94 firm fixed-price delivery order contract is for the provision of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The award is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a Firm Fixed Price Delivery Order valued at $41,649.97, is for the supply of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,931.76 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, and has an ultimate completion date of May 19, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,914.16 firm fixed-price delivery order is for the supply of 4554941547 Rituxan 500 mg/50 ml vials. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of...
This federal contract award, valued at $5,965.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4567104400 RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product, with an ultimate completion date of February 19, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order with a firm fixed-price pricing type. The contract, valued at $6,138.34, is awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to supply 4565456321 ! RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to the Department of Defense (DoD) healthcare facilities. The contract does not have a set-aside designation and is part of...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB24FZS81
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,138.34 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, and is not set aside for any specific business category.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This single-award IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain is reinforced by this IDC, which complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites.

Generated 12/18/24, 9:36 AM